ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,214.50
-0.10%
S&P ASX All Technology
3,562.20
0.19%
Brent Oil
78.695
-0.46%
US Dollar vs AUD
1.48126
-0.17%
Bitcoin
62,529.03
3.75%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Capricor Therapeutics Inc (CAPR) Share Price

Capricor Therapeutics Inc

Capricor Therapeutics Inc (CAPR)

Caprock Mining Corp
17.77
0.63
(3.68%)
At close: 12 October 7:00AM
Delayed by 15 minutes
17.53
-0.24
( -1.35% )
After Hours: 10:10AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
17.53
Bid
17.53
Offer
17.60
Volume
4,251,018
16.81 Day's Range 20.36
2.68 52 Week Range 21.98
Market Cap
570.407M
Previous Close
17.14
Open
18.5474
Last Trade
22
@
17.55
Last Trade Time
10:10:48
Financial Volume
US$ 77,074,808
VWAP
18.1309
Average Volume (3m)
2,658,302
Shares Outstanding
32,538,930
Dividend Yield
-
PE Ratio
-25.96
Earnings Per Share (EPS)
-0.69
Revenue
25.18M
Net Profit
-22.29M

About Capricor Therapeutics Inc

Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.capricor.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Capricor Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CAPR. The last closing price for Capricor Therapeutics was US$17.14. Over the last year, Capricor Therapeutics shares have traded in a share price range of US$ 2.68 to US$ 21.98.

Capricor Therapeutics currently has 32,538,930 shares in issue. The market capitalisation of Capricor Therapeutics is US$557.72 million. Capricor Therapeutics has a price to earnings ratio (PE ratio) of -25.96.

Ask ADVFN Intelligence (AI)

Capricor Therapeutics (CAPR) Options Flow Summary

CAPR Options Flow

Overall Flow

Bullish

Net Premium

206k

Calls / Puts

171.43%

Buys / Sells

80.00%

OTM / ITM

72.73%

Sweeps Ratio

0.00%

CAPR Latest News

More News

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

-Data Supports Deramiocel’s Sustained Efficacy and Safety in Treating DMD- -Improvements Seen in Multiple Cardiac and Skeletal Endpoints Demonstrating Stabilization of Cardiac and Skeletal Muscle...

10 hours ago
GlobeNewswire Inc.

Form 8-K - Current report

10 October 2024
Edgar (US Regulatory)

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

-Company Plans to Complete Rolling BLA Submission by End of 2024; Application May be Eligible for Priority Review by FDA- SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics...

10 October 2024
GlobeNewswire Inc.

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

SAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...

04 October 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

25 September 2024
Edgar (US Regulatory)

Form 8-K - Current report

25 September 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 September 2024
Edgar (US Regulatory)

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

-BLA to be Supported by Existing and Natural History Cardiac Data as Discussed with the FDA- -Initial Label Would Include All Patients with Cardiomyopathy Associated with Duchenne Muscular...

24 September 2024
GlobeNewswire Inc.

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of...

23 September 2024
GlobeNewswire Inc.

Form 8-K - Current report

17 September 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.5096-2.8248963391618.039621.9815.34495992219.45909119CS
413.25309.5794392524.2821.984.25730702412.69002734CS
1212.83272.9787234044.721.983.52265830212.10785547CS
2611.25179.1401273896.2821.983.52147122710.99629236CS
5214.63504.4827586212.921.982.6886850210.06182583CS
15613.59344.9238578683.9421.982.564069068.40489638CS
26015.03601.22.521.980.888549926.82766501CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
US$ 0.945701
(149.13%)
22.9M
XPONExpion360 Inc
US$ 3.10
(29.71%)
1.25M
NRXPNRX Pharmaceuticals Inc
US$ 1.59
(16.06%)
992
MDIAMediaco Holding Inc
US$ 1.30
(12.07%)
16.59k
PETZTDH Holdings Inc
US$ 1.40
(12.00%)
2.06k
MTEMMolecular Templates Inc
US$ 0.231
(-84.29%)
868.59k
ZPTAZapata Computing Holdings Inc
US$ 0.0838
(-67.89%)
4.96M
TWGTop Wealth Group Holding Ltd
US$ 5.63
(-21.15%)
4.24M
SPPLSIMPPLE Ltd
US$ 0.38
(-20.83%)
1.21M
NTRPNextTrip Inc
US$ 2.05
(-16.67%)
1.04k
TVGNTevogen Bio Holdings Inc
US$ 0.9401
(147.66%)
22.91M
JTAIJet AI Inc
US$ 0.0955
(-5.45%)
6.17M
ZPTAZapata Computing Holdings Inc
US$ 0.0838
(-67.89%)
4.96M
TWGTop Wealth Group Holding Ltd
US$ 5.63
(-21.15%)
4.24M
LUXHLuxUrban Hotels Inc
US$ 0.056
(5.66%)
2.91M

CAPR Discussion

View Posts
GreedyAgorist GreedyAgorist 3 hours ago
Fun day: up 18% first thing in AM, then down 17%, only to recover 5%. If you only looked at the modest 3.8% green at the end of the day, you might have no clue as to the action. Unless, of course, you've been here for more than a few days.

; - )

Must remember to keep powder dry and trigger finger limber for another one like that.
👍️0
ed3/6me ed3/6me 9 hours ago
Breather done. Told you16
👍️0
TechandBio TechandBio 10 hours ago
Shorts runnning for the hills 101 LOL lets chop them up!

$CAPR
👍️0
TechandBio TechandBio 12 hours ago
Sweet!

$40.00 Target!

$CAPR
👍️0
GreedyAgorist GreedyAgorist 1 day ago
Nevertheless, two days in a row of correction percentages was a bit much after almost all green for three weeks. Really three days of -10% if you start from the early morning top of Tuesday.

And as I type this, it seems to be bouncing quite strongly in the final hour or so. Will you accept 15.35 as low enough for that retracement?

: - )
👍️0
TechandBio TechandBio 1 day ago
Adding some vertical call debit spreads this morning for Q1 2025

$CAPR
👍️0
TechandBio TechandBio 2 days ago
Can't go straight up $40.00 Target in 2025 up 500%+ in 2024 was down 80% not that long big trend change.
$CAPR
👍️0
ed3/6me ed3/6me 2 days ago
Sounds right. You were smart if you sold out around 21. Buy back at 16
👍️0
XWAVXALMIMAN XWAVXALMIMAN 2 days ago
We went from 4 to 22, a gain of 18. If you follow Elliott Wave Theory and Fibonacci numbers, it would be normal to give back 38% of the gain before the next wave up. We should go down to 15.16 and then have a huge upward move up to 45.
👍️0
ed3/6me ed3/6me 2 days ago
people just taking profits. nothing new. as it drops it opens up new people to the company. does not hurt unless you sell in panic
👍️0
GreedyAgorist GreedyAgorist 2 days ago
Resistance hit yesterday; where is the support today? Is this thing looking to finish next week around 17.50? Open interest for October 18 options suggest a lot of people will be disappointed if this does not get back to 20 by then.

: - {

Right now, finishing at 15 next week is again a possibility. That, too, would be disappointing to many here.

Traders would probably file this under "buy the rumor, sell the news." Or buy before the conference; sell into the conference.
👍️0
TechandBio TechandBio 2 days ago
The pipeline is being overlooked Developing Transformative Cell and Exosome-based Therapeutic is going to tremendous.

$CAPR
👍️0
GreedyAgorist GreedyAgorist 3 days ago
I do not know; seems to be resistance once we get the 21 handle.

20% correction yesterday. Over 18% pop this morning. Lost about half that gain since then. Definitely getting bounced around.

I'm going to have to be more nimble if I want to open any more short term option contracts. (Only ten days to go.)
👍️0
TechandBio TechandBio 5 days ago
CAPR I'm up 480% YTD haven't sold a share. Looking for more appreciation!

$CAPR
👍️0
Mercedes99 Mercedes99 6 days ago
$30.00 by Nov 15th
👍️0
XWAVXALMIMAN XWAVXALMIMAN 6 days ago
Volcano called iron 8/21. Catching up on older posts. When do we get to 30?
👍️0
GreedyAgorist GreedyAgorist 1 week ago
So, it sounds like the answer is No. Neither of us has enough shares.

: - )

Well, I am definitely at least half right.

As for hitting that magical big round number target that people still dream about (even though inflation has destroyed the value, so it's just a number)... heck, I just need this quarter to be as good as last quarter, and I will be in good shape. It won't be as easy, as I don't think I have another quadruple like CAPR in my portfolio.

Looks like I just closed my October 20 call position at 2 bucks a contract. I know it is tempting to hold out for more when the thing is running, to wait and see where it ends up, but I opened that play a few days ago. My rule is: if immediately proved right, take profits; no need to wait until expiration. Besides, I also had October 15's. By cutting that position in half, I can let the rest (all house money) run. Well above the option strike price now. I will sell more cash covered puts if and when it dips.
👍️0
Volcano Volcano 1 week ago
Keep going up everyday
Billion dollars FDA approval guaranteed
👍️0
Volcano Volcano 1 week ago
I have enough shares to become millionaire
👍️0
XWAVXALMIMAN XWAVXALMIMAN 1 week ago
Congratulations to all longs who have kept the faith.
I am replying to my last post from 1/3/24. I am still holding my 50,000 shares since 2020. I sold some and bought back more. Last buy was 11/15/23 at 3.30. I have listened to every conference call. The last one was amazing. I like the way Linda is talking about other types of DMD and other kinds of cardiomyopathy. As you see with Ozempic, once a drug is approved for 1 indication, it can be used for whatever the doctor wants to prescribe it for as long as there is some research showing that it can help. I also like the way we are positioned to ramp up in Europe and Japan.

I think we are an excellent candidate to be bought out by Amgen or another big biotech or Pharma. I’m considering selling 10,000 shares and buying back 1.00 lower. If I could do that 3-4 times, I’ll be happy but I’ll be happier if I sell and never get the chance to buy back. Holding 40,000 shares until we go much higher or get bought out.

Let’s Go Mets!!
👍️0
GreedyAgorist GreedyAgorist 1 week ago
Are you averaging up like I am, Volcano? Or do you have enough shares? The price action sure suggests that some people definitely do not have enough.

: - )

I liked it when my average was less than 5/share. Now my average is just below 10. Oh, well, the action at the moment suggests that it is worth it. Apparently I like the action, as I have over 3 option contracts open for every 100 shares I actually hold.

Seems to be some resistance at 17.50, but ... go, Cap!
👍️ 1
Volcano Volcano 1 week ago
Unstoppable beast running
👍️0
GreedyAgorist GreedyAgorist 1 week ago
Ouch, that is a very pointy spike, 20% down from the morning top. That's what we call a correction. Something to keep the irrational exuberance in check, perhaps. Or shake out weak hands, as the hodlers say.

Now, will below 15 be seen as a bargain a month from now? Or next week? Or tomorrow? Or, more importantly for options traders, Friday October 18.
👍️0
dennisv dennisv 2 weeks ago
Higher Levels Are In The Works!
👍️0
steadykickin steadykickin 2 weeks ago
Congrats to those who have held through the years.......only the beginning.
👍️0
starkd748 starkd748 2 weeks ago
No in crypto
👍️0
Milesblue42 Milesblue42 2 weeks ago
The CALL Option have been bumped to $20

Super volcanic explosion now
Enjoy the ride to $30 this month

Institutional Money are picking up shares is what I'm hearing.
👍️0
Volcano Volcano 2 weeks ago
Super volcanic explosion now
Enjoy the ride to $30 this month
👍️0
GreedyAgorist GreedyAgorist 2 weeks ago
Looks like folks think under 10 is under-priced. I was surprised I was able to sell some puts on Friday. Happy today that I could.

If you don't mind my saying, Miles, you seem new to the board. How did you even find this ticker? I mean, despite the huge rally that started a couple of weeks ago and really accelerated last week, we have not come close to being deemed "hot" by Breakout Boards standards. Which is fine by me; if we remain under the radar for a while longer, that's OK.

Can this 20+% pop be sustained? I am not counting on it. I have seen these spikes before. As you can see by the chart, daily spikes and pumps that last a couple of days are not uncommon. But the promise of blessings from the FDA seem more realistic, so we are just here, bouncing around, wondering where the next plateau is for this stock.

Most think that a return to 5 is unlikely. Indeed, single digits should be a thing of the past if the latest price targets are to be believed. Some as high as 45. That seems incredible for even the most faithful* who have been here for the last five years. And it means fresh hope for anyone holding the bag for 10 years or more. I don't imagine many of those are still around. They probably booked their losses long ago.

*Except for Volcano. He is old faithful, always ready for this to blast off.
👍️0
Milesblue42 Milesblue42 2 weeks ago
WTF is going on??

😮
👍️0
ed3/6me ed3/6me 2 weeks ago
a few but not like last year
👍️0
enthalpy enthalpy 2 weeks ago
You still in on this?
👍️0
enthalpy enthalpy 2 weeks ago
Hey Ed I'm expecting $15 plus in October and $20 or $30 by eoy. Hope you still have your shares.
👍️0
GreedyAgorist GreedyAgorist 2 weeks ago
Dang, somebody grabbed some of my shares early. So much for patience. They did not want to wait until October 18. I think that is the earliest assignment I have experienced, 22 days early. That usually only happens with dividend payers that are well in the money. I don't often worry about shares getting called away early on a company that pays no dividend and is not profitable--not yet, anyway.

That's OK. That frees up funds that were going to be dead weight for three more weeks. Thank you very much. Although that means my average cost basis is going to read as much higher than it was a week ago. Oh, well, sometimes you average up after years of averaging down. I hope that early assignment wasn't a top signal. Sometimes it is, even with blue chips. Now, gee, what do I do with this extra cash...?
👍️0
GreedyAgorist GreedyAgorist 2 weeks ago
Second day of profit-taking after yesterday top. I know, we had three big up days (topping off two up weeks), but considering the top versus the close yesterday, already feels like we are in correction territory, down ~20% from that.

That's OK. If it cools off more, I will sell some more puts. Thanks to this week's action, I have options at every available strike price except 2.50. From October through January.

: - )

Congrats on your patience being rewarded. That is supposed to be the key to winning in the stock market... so I've heard.
👍️0
TechandBio TechandBio 2 weeks ago
Great week its been a long time but patience pays!

The Capr Team came through!

$CAPR
👍️0
Anshu2 Anshu2 2 weeks ago
Not AA, CAPR is going for FULL-APPROVAL.
👍️0
Anshu2 Anshu2 2 weeks ago
I have been in this for 4-5 years (frustratingly, most of the time). The current situation has two unique aspects.

1. FDA encouragement for BLA submission -- is a total surprise (even for CAPR). CAPR wasn't even thinking in this direction of cardiomyopathy --- and was encouraged by the FDA. That completely changes the fortune/future of a small company ($150m cap, 2 days ago).

2. The story is only 2 days old (and the market always takes time to factor in such huge news). The action of the last 2 days suggests that the market realizes (likely correctly) the sudden and radical change of the company's fortune. Multiple analysts now have a $40s PT.

My take: (i) The Chance of approval by mid-25 is very high (80-90%); look at the data presented yesterday morning. (ii) If approved, the stock should be $1-2B market cap ($30-60).

With the above in mind, play long-term (i.e., make a bet). Short-term --- there will be semi-random ups and downs.
👍️0
GreedyAgorist GreedyAgorist 2 weeks ago
Three dips today while hitting multi-year highs. Opportunity to get in or reminder that even the hottest tickers cool off?

Are profit-takers wrong or just doing what they do? Maybe thinking that usually when something pops, the odds of a drop only increase. Me, I remind myself that there are two sides to every spike; that is what makes them so pointy.

But I will give it to the promoters here. Doubling in a couple of days, price hitting triple what it was a couple of weeks ago ... arguments that the $5 trading range would be a thing of the past are looking legit. So where is the next plateau where we will hang out for a while? Double digit percentage gains every day this week ... is that sustainable? Some of my options orders will like that. Some are underestimating that.

By the time I finished typing this, one more big dip; price down another point. Gain of 25% not there any more. FOMO over? Still... another double digit gain. Maybe that makes two more such days possible. And more reasonable. It's kind of a shame we aren't even on the Hot Board yet. Not that I would want us to get to #1; that is always a sell signal. But completely flying under the radar--what's up with that?
👍️0
dennisv dennisv 2 weeks ago
High Pressure!
👍️0
TechandBio TechandBio 2 weeks ago
Just another day at the office!

What a year Viking, Summit, Wave, and Capricor those are my bios that hit so far!

$CAPR
👍️0
Volcano Volcano 2 weeks ago
Super volcanic explosion
PT $50
👍️0
TechandBio TechandBio 2 weeks ago
Complete Parabolic Mover got to see the angles before they are played
Examples SMMT $1.50 this year & CAPR $2.68 Patients and Forecasting pays!

CAPR double digits around the corner!

$CAPR
👍️0
TechandBio TechandBio 2 weeks ago
Hilarious listening to the boards about how awful the executive team was in the $2.00 area last year now they are the toast of the town.

$CAPR
👍️0
Volcano Volcano 2 weeks ago
safe to think AA is given in a few months
$100 coming sooner
👍️0
Monksdream Monksdream 2 weeks ago
CAPR new 52 week high
👍️0
TechandBio TechandBio 2 weeks ago
Patience Pays off been holding this since the 2.50 Level[color=red][/color]

$CAPR
👍️0
Volcano Volcano 2 weeks ago
$50 by Christmas time and $100 by Spring next year
Super volcanic explosion
👍️0
staynafloat staynafloat 2 weeks ago
LOL ... not even noon and we've traded over half the OS.
👍️0
tw0122 tw0122 2 weeks ago
CAPR 7.96 resistance and 30m float so now all those shares have to churn but shareholders taking profit after a long wait

$8.15 next resistance
👍️0

Your Recent History

NASDAQ
CAPR
Capricor Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved